10x Genomics TXG
$ 15.88
-3.58%
Quarterly report 2024-Q3
added 10-29-2024
10x Genomics Financial Ratios 2011-2024 | TXG
Annual Financial Ratios 10x Genomics
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-22.1 | -36.0 | -154.4 | -33.2 | -117.0 | - | -56.2 | - | - | - | - | - | - |
P/S |
9.1 | 11.6 | 18.3 | 60.2 | 14.9 | - | 14.8 | - | - | - | - | - | - |
EPS |
-2.2 | -1.5 | -0.5 | -5.4 | -0.8 | -8.4 | -1.6 | - | - | - | - | - | - |
EV (Enterprise Value) |
5.51 B | 5.98 B | 8.6 B | 17.5 B | 3.42 B | 279 M | 1.2 B | - | - | - | - | - | - |
EBITDA per Share |
-1.96 | -1.25 | -0.28 | -5.14 | -0.601 | - | -0.17 | - | - | - | - | - | - |
EV/EBITDA |
-274.4 | -31.4 | -138.8 | - | -72.0 | - | - | - | - | - | - | ||
PEG |
- | 0.06 | -2.61 | - | 149.18 | - | - | - | - | - | - | ||
P/B |
7.6 | 7.4 | 11.0 | 24.4 | 8.7 | - | -9.4 | - | - | - | - | - | - |
P/CF |
-371.4 | -177.8 | -420.6 | -82.6 | -449.3 | - | -73.0 | - | - | - | - | - | - |
ROE % |
-34.42 | -20.60 | -7.12 | -73.43 | -7.44 | - | 16.68 | - | - | - | - | - | - |
ROA % |
-26.43 | -16.13 | -5.71 | -58.40 | -5.16 | - | -24.81 | - | - | - | - | - | - |
ROCE % |
-35.80 | -20.84 | -6.39 | -72.27 | -5.63 | - | -34.37 | - | - | - | - | - | - |
Current Ratio |
4.3 | 4.6 | 5.1 | 4.9 | 7.6 | - | 3.1 | - | - | - | - | - | - |
DSO |
64.6 | 67.0 | 50.8 | 51.7 | 49.5 | - | 68.5 | - | - | - | - | - | - |
DIO |
135.4 | 214.7 | 221.5 | 141.2 | 91.3 | - | 167.2 | - | - | - | - | - | - |
DPO |
32.5 | 59.0 | 54.3 | 55.4 | 77.9 | - | 188.1 | - | - | - | - | - | - |
Operating Cycle |
200.0 | 281.6 | 272.3 | 192.8 | 140.9 | - | 235.7 | - | - | - | - | - | - |
Cash Conversion Cycle |
167.4 | 222.6 | 217.9 | 137.5 | 62.9 | - | 47.6 | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios 10x Genomics
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.3 | -0.32 | -0.5 | -0.79 | -0.53 | -0.44 | - | - | -0.57 | -0.38 | - | -0.15 | -0.1 | -0.11 | - | -0.65 | -0.41 | -0.22 | -0.07 | -0.33 | -0.7 | -0.25 | -5.4 | -1.13 | -0.45 | -1.23 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | -0.44 | - | - | -0.39 | - | - | -0.44 | -0.31 | - | -0.14 | -0.01 | -0.05 | - | -0.54 | -0.33 | -0.17 | - | -0.17 | -0.53 | -0.14 | - | -0.88 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-31.00 | -33.92 | -35.01 | -26.67 | -22.42 | -22.78 | -21.71 | -15.63 | -17.78 | -10.96 | -5.09 | -14.00 | -20.76 | -24.79 | -17.21 | -18.90 | -12.28 | -9.43 | -7.44 | 28.59 | 37.85 | 44.91 | 58.11 | 23.78 | 16.80 | 12.33 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-14.38 | -15.58 | -16.50 | -10.01 | -11.44 | -17.88 | -17.10 | -12.40 | -14.13 | -8.82 | -4.07 | -11.16 | -16.51 | -19.70 | -13.68 | -14.86 | -9.36 | -6.83 | -5.16 | -64.73 | -75.49 | -73.70 | -73.10 | -12.34 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-32.78 | -35.03 | -35.74 | -27.19 | -22.52 | -22.59 | -21.28 | -15.21 | -17.20 | -10.46 | -4.66 | -13.49 | -20.33 | -24.35 | -16.85 | -19.02 | -12.35 | -9.49 | -5.35 | 1.43 | 10.39 | 12.85 | 6.79 | 6.79 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
4.4 | 4.5 | 4.5 | - | - | 4.8 | 4.6 | - | 4.6 | 5.1 | 5.1 | 5.2 | 5.1 | 4.7 | 4.9 | 4.9 | 4.9 | 4.9 | 3.3 | 3.3 | 3.3 | 3.3 | 1.2 | 1.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
52.6 | 54.4 | - | - | - | 61.9 | - | - | 60.8 | 64.5 | - | 50.3 | 46.1 | 46.8 | - | 65.1 | 108.9 | 53.7 | 40.5 | 49.8 | 54.5 | 52.3 | 50.7 | 35.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
183.8 | 160.0 | - | - | - | 208.4 | - | - | 221.2 | 221.4 | - | 177.2 | 766.7 | 183.1 | - | 189.7 | 272.0 | 136.6 | - | 90.0 | 92.9 | 77.9 | - | 74.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
47.8 | 38.7 | - | - | - | 64.7 | - | - | 75.2 | 65.0 | - | 61.8 | 294.8 | 54.3 | - | 29.8 | 42.8 | 53.6 | - | 76.8 | 79.2 | 71.3 | - | 76.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
236.3 | 214.4 | 211.8 | - | - | 270.3 | - | - | 282.1 | 285.9 | - | 227.5 | 812.8 | 229.9 | - | 254.8 | 380.9 | 190.3 | 40.5 | 139.8 | 147.4 | 130.2 | 50.7 | 109.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
188.5 | 175.7 | 164.8 | - | - | 205.5 | - | - | 206.8 | 220.9 | - | 165.7 | 518.0 | 175.7 | - | 224.9 | 338.1 | 136.7 | 40.5 | 63.0 | 68.2 | 58.9 | 50.7 | 33.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency